STUTTGART, Germany, Sunday, October 15, 2006/BeverageMarketing/ -- Nautilus GmbH Laboratoriumsbedarf recently announced the launch of its new patent-pending xanthohumol supplement called BierMax™, during the Oktoberfest celebration ( muenchen.de/oktoberfest). Each BierMax capsule contains 333 mg. of Emed-XT™, standardized xanthohumol extract from hops (Humulus lupulus). All natural BierMax is produced by a proprietary freeze drying process that removes 100% of the water and alcohol from beer.
"The Vikings drank beer to give them strength and early British sailors carried it aboard ships to prevent scurvy," says Richard H. Davis, President of Beverage Marketing USA, Inc. "Most recently, scientist are looking at the compound xanthohumol and related anti-oxidant prenylflavonoids from hops found in beer constituents which may help prevent cancer or have other metabolic value." said Davis.
Oregon State University College of Health and Human Sciences and OSU's Linus Pauling Institute researchers have shown that xanthohumol inhibits NF-kappaB protein in cells along the surface of the prostate gland. The protein acts like a signal switch that turns on a variety of animal and human malignancies, including prostate cancer. The German Commission E monograph approved hops as a dietary supplement for mood disturbances such as restlessness and anxiety. Euromed S.A., a division of the German pharmaceutical firm Madaus AG, recently introduced a new hops extract Emed-XT containing a measured amount of xanthohumol.
Also under development is a non alcoholic xanthohumol beer and xanthohumol energy drink.
Nautilus GmbH Laboratoriumsbedarf, is the developer, manufacturer and marketer of BierMax. For more information visit http://www.biermax.com
These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.